{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:04:13Z","timestamp":1790345053961,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008368","name":"Gigtforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus University Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ero.2026.100190","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:07:05Z","timestamp":1778897225000},"page":"100190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["4-Octyl itaconate inhibits synovial fibroblast activation by targeting Nrf2 to exert anti-inflammatory effects in rheumatoid arthritis"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-358X","authenticated-orcid":false,"given":"Benedicte B.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Kemble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2922-3307","authenticated-orcid":false,"given":"Stinne","family":"Greisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Thyrsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1365-3938","authenticated-orcid":false,"given":"Vivien R.","family":"Schack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-9996","authenticated-orcid":false,"given":"Thomas B.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian K.","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6912-0674","authenticated-orcid":false,"given":"David","family":"Olagnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Croft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-1587","authenticated-orcid":false,"given":"Bent","family":"Deleuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1077-9727","authenticated-orcid":false,"given":"Morten A.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2026.100190_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.freeradbiomed.2018.03.042","article-title":"Hypoxia, oxidative stress and inflammation","volume":"125","author":"McGarry","year":"2018","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.ero.2026.100190_bib0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat Rev Rheumatol."},{"issue":"10086","key":"10.1016\/j.ero.2026.100190_bib0003","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ero.2026.100190_bib0004","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/annrheumdis-2012-202735","volume":"73","author":"H\u00f8rslev-Petersen","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ero.2026.100190_bib0005","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","article-title":"Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis","volume":"38","author":"Yu","year":"2019","journal-title":"Clin Rheumatol."},{"issue":"2","key":"10.1016\/j.ero.2026.100190_bib0006","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cei\/uxab021","article-title":"Metabolites as drivers and targets in rheumatoid arthritis","volume":"208","author":"Hanlon","year":"2022","journal-title":"Clin Exp Immun."},{"issue":"5","key":"10.1016\/j.ero.2026.100190_bib0007","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/metabo12050394","article-title":"A review of metabolomic profiling in rheumatoid arthritis: bringing new insights in disease pathogenesis, treatment and comorbidities","volume":"12","author":"Bartikoski","year":"2022","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.ero.2026.100190_bib0008","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep."},{"issue":"7760","key":"10.1016\/j.ero.2026.100190_bib0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","article-title":"Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis","volume":"19","author":"Bustamante","year":"2017","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.ero.2026.100190_bib0011","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/art.40504","article-title":"Review: synovial cell metabolism and chronic inflammation in rheumatoid arthritis","volume":"70","author":"Falconer","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.ero.2026.100190_bib0012","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cei.13228","article-title":"Altered metabolic pathways regulate synovial inflammation in rheumatoid arthritis","volume":"197","author":"Fearon","year":"2019","journal-title":"Clin Exp Immunol."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev."},{"key":"10.1016\/j.ero.2026.100190_bib0014","series-title":"Fibroblasts: Advances in Cancer, Autoimmunity and Inflammation","article-title":"Fibroblast like synovial cell subsets in rheumatoid arthritis","author":"Lomholt","year":"2021"},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01692-7","article-title":"Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis","volume":"11","author":"K\u00f8ster","year":"2021","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-024-03343-4","article-title":"Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis","volume":"26","author":"Qian","year":"2024","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.ero.2026.100190_bib0017","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41584-022-00771-x","article-title":"Cellular metabolic adaptations in rheumatoid arthritis and their therapeutic implications","volume":"18","author":"Fearon","year":"2022","journal-title":"Nat Rev Rheumatol."},{"issue":"5","key":"10.1016\/j.ero.2026.100190_bib0018","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/jcm8050753","article-title":"Can metabolic pathways be therapeutic targets in rheumatoid arthritis?","volume":"8","author":"Sanchez-Lopez","year":"2019","journal-title":"J Clin Med."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0019","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00011-017-1095-6","article-title":"Nrf2\/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion","volume":"67","author":"Xu","year":"2018","journal-title":"Inflamm Res."},{"issue":"4","key":"10.1016\/j.ero.2026.100190_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tibs.2008.12.008","article-title":"Nrf2 and KEAP1 mutations: permanent activation of an adaptive response in cancer","volume":"34","author":"Hayes","year":"2009","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.ero.2026.100190_bib0021","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bcp.2018.04.010","article-title":"Nrf2 as a therapeutic target for rheumatic diseases","volume":"152","author":"Ferr\u00e1ndiz","year":"2018","journal-title":"Biochem Pharmacol."},{"issue":"3","key":"10.1016\/j.ero.2026.100190_bib0022","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-Nrf2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol Rev."},{"key":"10.1016\/j.ero.2026.100190_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.bonr.2019.100228","article-title":"Nrf2 activation in osteoblasts suppresses osteoclastogenesis via inhibiting IL-6 expression","volume":"11","author":"Narimiya","year":"2019","journal-title":"Bone Reports"},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nature Commun."},{"key":"10.1016\/j.ero.2026.100190_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103077","article-title":"Regulation of immunomodulatory networks by Nrf2-activation in immune cells: redox control and therapeutic potential in inflammatory diseases","volume":"70","author":"Pant","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ero.2026.100190_bib0026","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2005.09.010","article-title":"3-Hydroxyanthranilic acid, one of L-tryptophan metabolites, inhibits monocyte chemoattractant protein-1 secretion and vascular cell adhesion molecule-1 expression via heme oxygenase-1 induction in human umbilical vein endothelial cells","volume":"187","author":"Pae","year":"2006","journal-title":"Atherosclerosis"},{"issue":"7699","key":"10.1016\/j.ero.2026.100190_bib0027","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ero.2026.100190_bib0028","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s42255-020-0210-0","article-title":"Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages","volume":"2","author":"Swain","year":"2020","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.ero.2026.100190_bib0029","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1089\/ars.2010.3835","article-title":"Deficiency of Nrf2 accelerates the effector phase of arthritis and aggravates joint disease","volume":"15","author":"Maicas","year":"2011","journal-title":"Antioxid Redox Signal."},{"issue":"11","key":"10.1016\/j.ero.2026.100190_bib0030","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/ard-2023-224898","article-title":"Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis","volume":"83","author":"Kieler","year":"2024","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.ero.2026.100190_bib0031","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.freeradbiomed.2023.07.016","article-title":"Nrf2 activation improves experimental rheumatoid arthritis","volume":"207","author":"Zhang","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ero.2026.100190_bib0032","article-title":"Aging relevant metabolite itaconate inhibits inflammatory bone loss","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.ero.2026.100190_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110255","article-title":"Itaconate reduces proliferation and migration of fibroblast-like synoviocytes and ameliorates arthritis models","volume":"264","author":"Tada","year":"2024","journal-title":"Clin Immunol."},{"issue":"5","key":"10.1016\/j.ero.2026.100190_bib0034","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41577-019-0128-5","article-title":"Itaconate: the poster child of metabolic reprogramming in macrophage function","volume":"19","author":"O\u2019Neill","year":"2019","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.ero.2026.100190_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6670464","article-title":"Knockdown of nrf2 exacerbates TNF-\u03b1-induced proliferation and invasion of rheumatoid arthritis fibroblast-like synoviocytes through activating JNK pathway","volume":"2020","author":"Du","year":"2020","journal-title":"J Immunol Res"},{"issue":"6","key":"10.1016\/j.ero.2026.100190_bib0036","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ero.2026.100190_bib0037","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"3","key":"10.1016\/j.ero.2026.100190_bib0038","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.ero.2026.100190_bib0039","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF01375656","article-title":"Characterization of SV40 T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-i, HLA-DR and some surface receptors","volume":"16","author":"Haas","year":"1997","journal-title":"Rheumatol Int."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0040","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1038\/s41467-018-05861-7","article-title":"Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming","volume":"9","author":"Olagnier","year":"2018","journal-title":"Nat Commun."},{"issue":"10","key":"10.1016\/j.ero.2026.100190_bib0041","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/rheumatology\/kew237","article-title":"A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritis","volume":"55","author":"Nielsen","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/acr2.11094","article-title":"Responses to cytokine inhibitors associated with cellular composition in models of immune-mediated inflammatory arthritis","volume":"2","author":"Nielsen","year":"2020","journal-title":"ACR Open Rheumatol."},{"issue":"2","key":"10.1016\/j.ero.2026.100190_bib0043","first-page":"301","article-title":"Fibroblast-like synovial cells derived from synovial fluid","volume":"32","author":"Stebulis","year":"2005","journal-title":"J Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0044","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1038\/s41467-024-48422-x","article-title":"Octyl itaconate enhances VSV\u039451 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways","volume":"15","author":"Kurmasheva","year":"2024","journal-title":"Nat Commun."},{"issue":"5","key":"10.1016\/j.ero.2026.100190_bib0045","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jcmm.17185","article-title":"4-Octyl itaconate inhibits lipopolysaccharide (LPS)-induced osteoarthritis via activating Nrf2 signalling pathway","volume":"26","author":"Zhang","year":"2022","journal-title":"J Cell Mol Med."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0046","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42358-023-00287-2","article-title":"Correction to: morphofunctional analysis of fibroblast-like synoviocytes in human rheumatoid arthritis and mouse collagen-induced arthritis","volume":"63","author":"Machado","year":"2023","journal-title":"Adv Rheumatol."},{"key":"10.1016\/j.ero.2026.100190_bib0047","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fphys.2020.00347","article-title":"Metabolic checkpoints in rheumatoid arthritis","volume":"11","author":"Pucino","year":"2020","journal-title":"Front Physiol."},{"issue":"7","key":"10.1016\/j.ero.2026.100190_bib0048","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immun."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0049","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s11658-023-00503-3","article-title":"Metabolite itaconate in host immunoregulation and defense","volume":"28","author":"Yang","year":"2023","journal-title":"Cell Mol Biol Lett."},{"issue":"3","key":"10.1016\/j.ero.2026.100190_bib0050","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/03009742.2024.2392364","article-title":"Plasma haem oxygenase-1 may represent a first-in-class biomarker of oxidative stress in rheumatoid arthritis","volume":"54","author":"Andersen","year":"2025","journal-title":"Scand J Rheumatol."},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0051","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of Nrf2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat Commun."},{"issue":"8","key":"10.1016\/j.ero.2026.100190_bib0052","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/jor.22630","article-title":"Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints","volume":"32","author":"Bajpayee","year":"2014","journal-title":"J Orthop Res."},{"key":"10.1016\/j.ero.2026.100190_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103134","article-title":"Biomarkers of Nrf2 signalling: current status and future challenges","volume":"72","author":"Morgenstern","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ero.2026.100190_bib0054","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaci.2011.03.029","article-title":"Opposing effects of nasal epithelial NAD(P)H dehydrogenase quinine 1 and heme oxygenase 1 expression on upper and lower airway symptoms in adolescents with asthma","volume":"128","author":"Noel","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ero.2026.100190_bib0055","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7943495","article-title":"Antioxidant functions of the aryl hydrocarbon receptor","volume":"2016","author":"Dietrich","year":"2016","journal-title":"Stem Cells Int."}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708126000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:31:58Z","timestamp":1790343118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708126000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S3050708126000893"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2026.100190","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"4-Octyl itaconate inhibits synovial fibroblast activation by targeting Nrf2 to exert anti-inflammatory effects in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2026.100190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}],"article-number":"100190"}}